NCT05733559View on ClinicalTrials.gov

QIAstat-Dx® Respiratory Panel Plus (RPP) Clinical Performance Study

CompletedOBSERVATIONAL
Enrollment

565

Participants

Timeline

Start Date

February 23, 2023

Primary Completion Date

May 3, 2023

Study Completion Date

October 11, 2023

Conditions
Respiratory Disease
Interventions
DEVICE

QIAstat-Dx® Respiratory Panel Plus (RPP)

An observational prospective performance evaluation study of QIAstat-Dx® Respiratory Panel Plus (RPP) SARS-CoV-2 target against a marketed comparator, using NPS collected per the manufacturer's instructions and eluted in Universal Transport Media (UTM) from subjects with signs and symptoms of respiratory infection

Trial Locations (1)

Unknown

QIAGEN, Manchester

All Listed Sponsors
lead

QIAGEN Gaithersburg, Inc

INDUSTRY